Login | Register
 Username 
 Password 
 
Login

HIV ATLAS

HIV :: TUBERCULOSIS :: MALARIA

Primary links

  • HOME
    • About Us
    • Contact Us
  • CLASSIFIED BLOGS
  • JOBS
  • EVENTS
  • LINKS
  • DAILY WIRE
  • VIDEOS
  |  
Home Blogs mark's blog

Featured Jobs

  • Dean - Indian Institute of Advanced Nursing, Chennai
  • Research Capacity Building Advisor, Haiti
  • Vacancy announcement in Afghanistan
  • Chief of Party- Kenya Public Health
  • Chief of Party/Technical Advisor, HIV-Haiti
  • DEPUTY CHIEF OF PARTY, RUSSIA
  • CHIEF OF PARTY, RUSSIA
  • Chief of Party, India
  • Chief of Party- Kenya
  • Namibia Department of Defense Program Lead

Events

  • Aids in Culture VI: Explorations in the Cultural History of AIDS International Conference. Mexico City, 9 - 14 December 2010
  • Sexual Health Conference in Bali, May 4-6
  • CBCP calls for summit on HIV-AIDS - ABS CBN News
  • ASEAN youth meet to map out HIV/AIDS prevention activities - Xinhua
  • Gujarat - Get togehter 3000 PLHAs at Capital of Gujarat
  • International Symposium on HIV & Emerging Infectious Diseases.
  • India NGO Awards 2009
  • HIV Congress 2010
  • January 2010 Free POZ Weekend Seminar in LA!
  • National meet on immunology at MSU - Times of India

[Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuber

Submitted by mark on Sat, 07/25/2009 - 17:11
  • Abstracts and Research
  • World Wide

[Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates] - Related Articles
[Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates]
Mikrobiyol Bul. 2009 Apr;43(2):217-26
Authors: Aslan G, Tezcan S, Emekdaş G
Rapid identification of resistant Mycobacterium tuberculosis complex isolates is quite important for the establishment of early and appropriate therapy. The Genotype MTBDR (Hain Lifescience, Nehren, Germany) is a commercially available DNA strip assay designed for the rapid detection of rpoB and katG gene mutations in clinical isolates. This study was conducted to determine the mutation types of phenotypically drug resistant 26 M. tuberculosis complex clinical isolates [15 isoniazid (INH), 1 rifampin (RMP) and 10 INH and RMP resistant] by Genotype MTBDR (G-MTBDR) DNA strip assay and to compare the diagnostic performance of this test. Sixteen of 25 (64%) INH-resistant and 9 of 11 (81.8%) RMP-resistant clinical isolates were correctly identified with the presence of hybridization in mutation probe or lack of hybridization at least by one of the wild type probes, by G-MTBDR assay. Hybridization with mutation probes was detected in only 5 of the RMP resistant isolates. We observed rpoB MUT3 (S531L, Ser-->4Leu) mutation in 4 and rpoB MUT1 (D516V) in one of these isolates. In 56% (14/25) of the INH-resistant isolates, katG T1 (S315T1) hybridization pattern was observed at katG mutation probe. G-MTBDR assay couldn't identify two of the 11 (18.2%) RMP-resistant isolates and one of these iSolates was shown to have a mutation at codon 531 (TCG-GCG) and the other at codon 545 (CTG-->ATG), possibly not associated with resistance, by sequence analysis. In four of the eight (8/25; 32%) INH-resistant isolates not identified by G-MTBDR assay, DNA cycle sequencing revealed different nucleotide changes outside the most common mutation zone. One of these were at codon 293 (GCT-->ACT) in katG, one with dual mutation at 279 (GGC-->ACC) in katG and at 15th C-->T in inhA gene, one at 15th C-->T in inhA gene and one at 279 (GGC-->ACC) in katG gene region. DNA membrane strip assay can be a use ful tool for the rapid detection of resistant M. tuberculosis complex isolates and therefore accelerate th initiation of the appropriate treatment. However, due to its restrictions in the determination of relatively rare mutations, this rapid screening test should be used together with conventional susceptibility tests in routine laboratory practices.
PMID: 19621606 [PubMed - in process]
[Tuberculosis Pulmonary]

  • mark's blog
  • Login or register to post comments
  • Printer-friendly version

RESOURCES

  • AEGiS
  • AIDS.gov
  • AIDS_ASIA
  • AIDS-INDIA
  • AIDSPORTAL.org
  • About.com
  • Aids-write.org
  • All Africa.com
  • CDC
  • Children & HIV
  • Clinical Care Options HIV
  • DailyMed
  • EATG
  • EBLING LIBRARY
  • Eldis-Jobs
  • Eldis.org
  • GNP Latest news
  • Google-Homophobia
  • Google-HIV Baby-sitting
  • Google HIV NEWS
  • Google MALARIA NEWS
  • Google TB NEWS
  • HIV Law Project
  • HIV Positive Dating
  • HIV Twinning News
  • Hivdatfla
  • Hivsnp
  • IAVI
  • IFANET-INDIA
  • IGIB/CSIR
  • DevNetJobs
  • Indeed.com
  • Iran HIV AIDS
  • Juju-HIV
  • Kaiser-Child health
  • Kaiser HIV/AIDS
  • Kaiser Malaria
  • Kaiser-Tuberculosis
  • Kaiser-U.S. HIV
  • Medical News-HIV
  • Medical News-TB
  • MEDSCAPE
  • Medsin Manchester
  • National AIDS Map
  • Nature Jobs
  • Nets at Harvard University
  • NIAID
  • NMAC
  • NIH.gov
  • NMPrev
  • OpenSource.org.in
  • Oxfam Jobs
  • Partners Zambia
  • Policy and Ethics
  • PozHealth
  • PubMed-HIV
  • PubMed-Malaria
  • RBM Topline Stories
  • SAATHII
  • Save The Children
  • Treatment Action Campaign
  • Tuberculous-Meningitis
  • Tuberculosis-Pulmonary
  • UKLug-HIV
  • UKLug-Tuberculosis
  • UNAIDS-JOBS
  • UNAIDS-SERVICE
  • UNICEF News
  • UNICEF Photo Essays
  • WHO
  • Women & HIV
Every 9½ minutes someone in the US is infected with HIV. Act Against AIDS. Get the facts: NineAndaHalfMinutes.org

ABOUT HIV ATLAS

A Social Media initiative that aims to Collect, Collate, Classify and Disseminate the information on HIV, TB & Malaria so that people living with HIV and the people working in the field can be on top of the information generating from more than 700 online and offline resources.

HIV ATLAS provides its users a unique way to be on top of information ranging from common living to funding, jobs, events and much more absolutely free of charge. We encourage Employers to post their Job opportunities in our featured Jobs cateogry to reach out to more than 40000 subscribers daily.

JOIN HIV ATLAS

HIV ATLAS welcomes content contributions and strongly encourages all sector participants to actively share their advertisements.

You can contribute and engage by:
- Creating your profile
- Posting your classified advertisements
- sharing information about Jobs, Events, Funding etc with us
- sharing information about any online resource you want us to include
- creating your resume for potential employers to have a look in.

NEWLETTER SUBSCRIPTIONS

Manage your newsletter subscriptions
Select the newsletter(s) to which you want to subscribe or unsubscribe.
  Copyright © 2004-2009 HIV ATLAS.org. All rights reserved. | Legal | Contact Powered by Halosys Technologies Inc.  

Disclaimer: This site contains HIV prevention messages that may not be appropriate for all audiences.